ArticleBlood2014

Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma.

Ian W Flinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.